NCT00026039

Brief Summary

To determine if estrogen hormone replacement therapy reduces the risk of stroke or death in postmenopausal women who have already had stroke or a transient ischemic attack (TIA).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1993

Completed
7.9 years until next milestone

First Submitted

Initial submission to the registry

November 7, 2001

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 8, 2001

Completed
Last Updated

May 15, 2006

Status Verified

November 1, 2005

First QC Date

November 7, 2001

Last Update Submit

May 12, 2006

Conditions

Stroke

Keywords

strokeestrogen

Interventions

estrogenDRUG

Sponsors & Collaborators

MeSH Terms

Conditions

Stroke

Interventions

Estrogens

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

HormonesHormones, Hormone Substitutes, and Hormone AntagonistsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and Uses

Study Officials

  • Ralph I. Horwitz, M.D.

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Sponsor Type
NIH

Study Record Dates

First Submitted

November 7, 2001

First Posted

November 8, 2001

Study Start

December 1, 1993

Last Updated

May 15, 2006

Record last verified: 2005-11